English Division Final Test 2022 (correct answers)

1. Nuclear medicine:
a. uses unsealed sources of radiation for diagnosis and therapy
b. uses external beam radiation for treatment of neoplasms
c. correct a and b
d. none of the above

2. In nuclear medicine gamma emitters are used:

a. in radionuclide therapy
b. in diagnostic imaging
c. for delivering radiation dose to the target volume
d. none of the above

3. No tracer uptake in one kidney can mean:

a. agenesis of this kidney
b. thrombosis of the artery supplying this kidney
c. hyperfunctioning of the contralateral kidney
d. correct a and b

4. Lack of uptake of radiotracer in the thyroid gland can be due to:

a. administration of contrast media containing iodine
b. treatment with anti-thyroid drugs
c. treatment with thyroxine
d. all above

5. Indications for radioiodine treatment are:

a. Graves-Basedow disease
b. differentiated thyroid cancer
c. multinodular goiter
d. all above

6. Main indication for bone ‘whole body’ scintigraphy is:

a. osteopenia
b. osteoporosis
c. bone metastases
d. degenerative joint disease

7. Indication for lung perfusion scintigraphy is:

a. COPD
b. tuberculosis
c. pulmonary embolism
d. atelectasis

8. Nuclear medicine procedures with technetium-99m:

a. usually should not be performed in pregnant women
b. can not be performed in renal failure
c. are a common cause of allergies
d. are characterized by high toxicity

9. Before oncological FDG-PET study patient preparation include:

a. physical activity few hours prior to the study
b. oral administration of 100g of glucose
c. 4-6 hour fastening
d. fatty diet a day prior to the study

10. 68Ga-PSMA PET/CT is a valuable tool for:

a. detecting renal cancer
b. measuring PSA level in blood
c. detection disease foci in biochemically relapsed prostate cancer
d. none of above
11. Radiotherapy planning of NSCLC should be based on:
a. CT
b. CT and FDG-PET
c. CT and MRI
d. CT, MRI, and FDG-PET

12. FDG-PET is NOT routinely applied in:

a. Lymphoma
b. Melanoma
c. Lung cancer
d. Urinary bladder cancer

13. FDG-PET is necessary in the management of Hodgkin lymphoma for:

a. initial staging of disease
b. early response assessment after 2 cycle of chemotherapy
c. response assessment after complete therapy
d. all above

14. Myocardial perfusion imaging:

a. is applied in the assessment of cardiac ischaemia
b. is performed after intravenous injection of gallium-67
c. requires imaging in stress and rest conditions
b. correct answers are a and c

15. Intense and symmetrical radiotracer uptake in long bones, skull and sternum in bone scan:
a. is not possible
b. suggests bone metastases
c. suggests metabolic bone disease (e.g. Paget’s)
d. suggests primary bone tumors

16. Beta (-) emitters in nuclear medicine are used:

a. in PET imaging
b. in radionuclide therapies
c. a and b are true
b. are not used at all

17. Lymphoscintigraphy:
a. is used to diagnose primary lymphedema
b. is used to diagnose secondary lymphedema
c. is used for localizing of sentinel lymph nodes
d. correct a, b and c

18. Static renal scintigraphy (radiotracer 99mTc-DMSA) is frequently applied in diagnosing:

a. urine outflow problems
b. scarring of renal parenchyma
c. renal cancer
b. renal ectopy

19. An indication for brain perfusion scintigraphy (SPECT) is/are:

a. neurodegenerative diseases (e.g. Alzheimer disease, Parkinson disease)
b. cerebrovascular diseases
c. epilepsy
d. all above

20. Which of the following is/are true?

a. gamma camera and PET are basic imaging tools in nuclear medicine
b. the most common imaging radionuclide for PET is fluorine-18
c. the most common therapeutic radioactive isotope is technetium-99m
d. correct a and b